←AIPArterisOur view: NeutralFull analysisעברית
Updated 16 Nov 2026
The company · 1 · Who is this company?

Arteris designs the network inside other companies' chips

Chip networks

let a chip's parts pass data to each other

Licences

chipmakers pay to use its design

Royalties

a fee on every chip shipped

A modern chip holds processors, memory and special engines that pass data constantly. Arteris sells the design for the network that carries that data, so chipmakers need not build their own.

The company · 2 · What exactly does it sell?

Licences bring 85% of sales; royalties a tenth

Each $1 of sales, first half of 2026
85%10%5%
Licences and supportRoyalties per chip shippedEngineering help

A chipmaker pays a licence fee to design with Arteris's network, then a royalty on each chip it sells. Only 14% of chip projects work first time, so a proven design matters.

The company · 3 · How does it make money?

It still loses money once share pay is counted

26%of 2025 sales paid to staff in shares
$1.2Mloss before share pay last quarter, from $3.5M
$131.4Msigned work not yet billed

Research and office costs rise slower than sales, so the loss shrinks each year. But share pay and selling costs grow as fast as sales, and the share count rose 11% in seven months.

Is it a good business? · 4 · What gives it an edge?

Once a chip family uses it, switching is costly

83

new chip designs started on it in 2025, from 76

About $12.2M

to design a complex chip, against a small fee

A chip's settings, testing and safety approvals are built around the network, so a chipmaker keeps using it for the next generation. One crack: Mobileye now holds rights to a rival's network patents.

Is it a good business? · 5 · What is the catch?

The biggest rival is the customer's own engineers

Qualcomm, Inteleach bought a network business of their own
Armbundles its own network with its designs
Cadence, Bayalaunched rival networks

Listed rivals: QCOM · INTC · ARM · CDNS · MBLY

The largest chipmakers can build this themselves. Baya, a funded start-up, already shares a customer with Arteris.

Is it a good business? · 6 · What does its record show?

Sales more than doubled in four years

Sales, $M
37.9
50.4
53.7
57.7
70.6
93.0
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales, latest quarter+48%to $25.8M
Signed yearly income$103.8Myearly contract value plus royalties, up 39%
Forecast$98.5M-$99.5M2026 sales forecast, raised for the third time

Each new dollar of sales loses a little less than the last. The question is whether the loss ends once the cost of paying staff in shares is counted.

Is it a good business? · 7 · How much room is there to grow?

Nobody publishes this market's size today

About $109Mthe last outside count of the market, for 2019
$9.45Bchip designs sold as licences in 2025
+22.2%growth of the part holding these networks

Arteris held about a third in 2019. Growth comes from each chip needing a bigger network, not from more chip projects.

Is it a good business? · 8 · Who is in charge?

The long-time chief owns most of the insider stake

Since 2005Charles Janac as chief executive
About 23%owned by insiders, mostly him

His yearly bonus pays on goals the company does not name, and his share awards vest just for staying. A new finance chief started in September 2026.

The story right now · 9 · Why does AI help Arteris?

AI chips need bigger networks inside them

-57.6%the shares from their 30 June high
6 buys, 1 holdanalysts' ratings

AI chips cram more processors onto one piece of silicon, and every one must pass data quickly. That makes the network inside a bigger and harder job, which is what Arteris sells.

The story right now · 10 · Is Arteris really near a profit?

A company can show profit by leaving out share pay

  1. Staff are paid partly in sharesNo cash leaves the company.
  2. Adjusted figures leave it outThe loss looks small.
  3. But owners payNew shares split the company further.
  4. Counting it, the loss is large57.6% of sales last quarter.

Paying in shares is a real cost: each existing share owns a little less of the company. Analysts expect an adjusted profit soon; we count the share pay too.

The story right now · 11 · What changed lately?

Sales grew 48% and the adjusted loss shrank

+48%third-quarter sales
$1.2Mloss before share pay, from $3.5M
Q4 2026a first adjusted profit is possible, not promised
-57.6%the shares from the June high, with no bad news

Solid quarter

The business kept growing through the fall in the shares. Share pay still dwarfs the adjusted loss, so the profit question stays open.

The story right now · 12 · What is everyone arguing about?

Are the losses ending, or just left out?

Many investors think

An AI chip winner whose losses are about to end

We think

The growth is real, but the losses come from paying staff in shares

We would be wrong if a profit before share pay arrives this quarter while share pay falls below a fifth of sales and growth stays above 25%.

The price and our view · 13 · What is a share worth?

No single value here: it is priced as a bet

We put no single value on a share here, because the business does not yet earn a lasting profit. Instead we ask what the shares pay if the plan works, and what is left if it fails.

The price and our view · 14 · How could we be wrong?

Paid in shares, and customers can build it

Paid in sharesBiggest

Share pay was 26% of 2025 sales.

Customers build itWatch

Big chipmakers keep their own teams.

China is a quarterShowing now

24.5% of 2025 sales, barely growing.

MobileyeUnknown

Whether its newest chips still use Arteris.

Some sales go to companies on a US export blacklist, and costs rose almost as fast as sales in early 2026.

The price and our view · 15 · How will we know?

February tests the profit and the 2027 forecast

Signed yearly income reaches $106MGood sign
An adjusted fourth quarter at zero or betterGood sign
2027 sales growth forecast below 15%We turn negative
FEB 2027-

Fourth-quarter results and the 2027 forecast. Companies report every three months; each report is a test of the story.

Our view also changes on price alone: we turn positive if the shares fall far enough to leave room for profit to fall short.

The price and our view · 16 · So, what do we think?

Real growth inside others' chips, profit still a promise

NeutralMedium conviction

Arteris is growing fast inside a rising number of chips. But it still loses money once share pay is counted, and big chipmakers can build their own. The price already pays for profit that is still a promise. Neutral.

↑ ↓ to move · C for contents